Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s Disease

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s Disease. / Li, Terry; Click, Benjamin; Bachour, Salam; Sachs, Michael; Barnes, Edward L.; Cohen, Benjamin L.; Contreras, Susell; Axelrad, Jordan.

In: Digestive Diseases and Sciences, Vol. 68, 2023, p. 3596–3604.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Li, T, Click, B, Bachour, S, Sachs, M, Barnes, EL, Cohen, BL, Contreras, S & Axelrad, J 2023, 'Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s Disease', Digestive Diseases and Sciences, vol. 68, pp. 3596–3604. https://doi.org/10.1007/s10620-023-08044-7

APA

Li, T., Click, B., Bachour, S., Sachs, M., Barnes, E. L., Cohen, B. L., Contreras, S., & Axelrad, J. (2023). Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s Disease. Digestive Diseases and Sciences, 68, 3596–3604. https://doi.org/10.1007/s10620-023-08044-7

Vancouver

Li T, Click B, Bachour S, Sachs M, Barnes EL, Cohen BL et al. Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s Disease. Digestive Diseases and Sciences. 2023;68:3596–3604. https://doi.org/10.1007/s10620-023-08044-7

Author

Li, Terry ; Click, Benjamin ; Bachour, Salam ; Sachs, Michael ; Barnes, Edward L. ; Cohen, Benjamin L. ; Contreras, Susell ; Axelrad, Jordan. / Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s Disease. In: Digestive Diseases and Sciences. 2023 ; Vol. 68. pp. 3596–3604.

Bibtex

@article{c32929882d1a47b9aa32df9f57e93163,
title = "Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn{\textquoteright}s Disease",
abstract = "Background: Crohn{\textquoteright}s disease recurrence after ileocecal resection is common. Guidelines suggest colonoscopy within 6–12 months of surgery to assess for post-operative recurrence, but use of adjunctive monitoring is not protocolized. We aimed to describe the state of monitoring in post-operative Crohn{\textquoteright}s. Methods: We conducted a retrospective study of patients with Crohn{\textquoteright}s after ileocolic resection with ≥ 1-year follow-up. Patients were stratified into high and low risk based on guidelines. Post-operative biomarker (C-reactive protein, fecal calprotectin), cross-sectional imaging, and colonoscopy use were assessed. Biomarker, radiographic, and endoscopic post-operative recurrence were defined as elevated CRP/calprotectin, active inflammation on imaging, and Rutgeerts ≥ i2b, respectively. Data were stratified by surgery year to assess changes in practice patterns over time. P-values were calculated using Wilcoxon test and Fisher exact test. Results: Of 901 patients, 53% were female and 78% high risk. Median follow-up time was 60 m for LR and 50 m for high risk. Postoperatively, 18% low and 38% high risk had CRPs, 5% low and 10% high risk had calprotectins, and half of low and high risk had cross-sectional imaging. 29% low and 38% high risk had colonoscopy by 1 year. Compared to pre-2015, time to first radiography (584 days vs. 398 days) and colonoscopy (421 days vs. 296 days) were significantly shorter for high-risk post-2015 (P < 0.001). Probability of colonoscopy within 1 year increased over time (0.48, 2011 vs. 0.92, 2019). Conclusion: Post-operative colonoscopy completion by 1 year is low. The use of CRP and imaging are common, whereas calprotectin is infrequently utilized. Practice patterns are shifting toward earlier monitoring.",
keywords = "Biomarkers, C-reactive protein, Calprotectin, Crohn{\textquoteright}s disease, Inflammatory bowel disease, Post-operative recurrence",
author = "Terry Li and Benjamin Click and Salam Bachour and Michael Sachs and Barnes, {Edward L.} and Cohen, {Benjamin L.} and Susell Contreras and Jordan Axelrad",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",
year = "2023",
doi = "10.1007/s10620-023-08044-7",
language = "English",
volume = "68",
pages = "3596–3604",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer",

}

RIS

TY - JOUR

T1 - Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s Disease

AU - Li, Terry

AU - Click, Benjamin

AU - Bachour, Salam

AU - Sachs, Michael

AU - Barnes, Edward L.

AU - Cohen, Benjamin L.

AU - Contreras, Susell

AU - Axelrad, Jordan

N1 - Publisher Copyright: © 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

PY - 2023

Y1 - 2023

N2 - Background: Crohn’s disease recurrence after ileocecal resection is common. Guidelines suggest colonoscopy within 6–12 months of surgery to assess for post-operative recurrence, but use of adjunctive monitoring is not protocolized. We aimed to describe the state of monitoring in post-operative Crohn’s. Methods: We conducted a retrospective study of patients with Crohn’s after ileocolic resection with ≥ 1-year follow-up. Patients were stratified into high and low risk based on guidelines. Post-operative biomarker (C-reactive protein, fecal calprotectin), cross-sectional imaging, and colonoscopy use were assessed. Biomarker, radiographic, and endoscopic post-operative recurrence were defined as elevated CRP/calprotectin, active inflammation on imaging, and Rutgeerts ≥ i2b, respectively. Data were stratified by surgery year to assess changes in practice patterns over time. P-values were calculated using Wilcoxon test and Fisher exact test. Results: Of 901 patients, 53% were female and 78% high risk. Median follow-up time was 60 m for LR and 50 m for high risk. Postoperatively, 18% low and 38% high risk had CRPs, 5% low and 10% high risk had calprotectins, and half of low and high risk had cross-sectional imaging. 29% low and 38% high risk had colonoscopy by 1 year. Compared to pre-2015, time to first radiography (584 days vs. 398 days) and colonoscopy (421 days vs. 296 days) were significantly shorter for high-risk post-2015 (P < 0.001). Probability of colonoscopy within 1 year increased over time (0.48, 2011 vs. 0.92, 2019). Conclusion: Post-operative colonoscopy completion by 1 year is low. The use of CRP and imaging are common, whereas calprotectin is infrequently utilized. Practice patterns are shifting toward earlier monitoring.

AB - Background: Crohn’s disease recurrence after ileocecal resection is common. Guidelines suggest colonoscopy within 6–12 months of surgery to assess for post-operative recurrence, but use of adjunctive monitoring is not protocolized. We aimed to describe the state of monitoring in post-operative Crohn’s. Methods: We conducted a retrospective study of patients with Crohn’s after ileocolic resection with ≥ 1-year follow-up. Patients were stratified into high and low risk based on guidelines. Post-operative biomarker (C-reactive protein, fecal calprotectin), cross-sectional imaging, and colonoscopy use were assessed. Biomarker, radiographic, and endoscopic post-operative recurrence were defined as elevated CRP/calprotectin, active inflammation on imaging, and Rutgeerts ≥ i2b, respectively. Data were stratified by surgery year to assess changes in practice patterns over time. P-values were calculated using Wilcoxon test and Fisher exact test. Results: Of 901 patients, 53% were female and 78% high risk. Median follow-up time was 60 m for LR and 50 m for high risk. Postoperatively, 18% low and 38% high risk had CRPs, 5% low and 10% high risk had calprotectins, and half of low and high risk had cross-sectional imaging. 29% low and 38% high risk had colonoscopy by 1 year. Compared to pre-2015, time to first radiography (584 days vs. 398 days) and colonoscopy (421 days vs. 296 days) were significantly shorter for high-risk post-2015 (P < 0.001). Probability of colonoscopy within 1 year increased over time (0.48, 2011 vs. 0.92, 2019). Conclusion: Post-operative colonoscopy completion by 1 year is low. The use of CRP and imaging are common, whereas calprotectin is infrequently utilized. Practice patterns are shifting toward earlier monitoring.

KW - Biomarkers

KW - C-reactive protein

KW - Calprotectin

KW - Crohn’s disease

KW - Inflammatory bowel disease

KW - Post-operative recurrence

U2 - 10.1007/s10620-023-08044-7

DO - 10.1007/s10620-023-08044-7

M3 - Journal article

C2 - 37548896

AN - SCOPUS:85166938167

VL - 68

SP - 3596

EP - 3604

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

ER -

ID: 362681191